Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection.

"data availability the datasets generated for this study are published in the dryad"

"I have read the journal’s policy and the authors of this manuscript have the following competing interests: CB is an expert paid consultant on ancestry and diversity for Roche/Genentech. The other authors have no competing interests."

"This work was supported by the Fundação de Amparo à Pesquisa do Estado de São Paulo (12/50273-0 to MASY, 2014/0781-1 - Technical Training scholarship to FDB, 2013/15122-4- Scientific Initiation Scholarship to CMRO), Coordenação de Aperfeicoamento de Pessoal de Nível superior, CAPES - doctoral scholarship to SCVS – 2010 to 2015), National Council for Scientific and Technological Development (CNPq - 314661/2021- 2 - Research Productivity Grant to CB). The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript."